At Yale, our goal is to achieve impact not income. We do strive to put people over profit. These are personal mantras of mine, and the motivation behind the work we do at OCR. Along with colleagues at the Yale School of Public Health (YSPH), Yale Pathology Lab (YPL), and several passionate partners across the country, our office recently had the honor of being part of an exciting announcement that makes good on that mission. We also successfully hosted our first large-scale webinar, the Blavatnik Fund for Innovation at Yale Showcase. To all those who joined us, to our presenters, thank you. We were able to facilitate several introductions for our talented Blavatnik awardees with VCs and industry partners. Now in its 5th year, we are currently accepting applicants for 2021 Blavatnik funding. More information about the application process can be found in our OCR Report.
Jon Soderstrom
Managing Director
Yale Office of Cooperative Research
What's coming up
Now Accepting Applications for
2021 Blavatnik funding
Deadline: 10/26/20 by 5 PM EST
Do you have patentable research data that you believe could make an impact in the outside world? We invite you to apply for the Blavatnik Fund for Innovation at Yale. The outcome could be an award of between $100 and $300K (announced May 2021) to help you translate your research discoveries into strong projects with commercial potential. The OCR and Blavatnik teams are here to help at every stage. For any questions, please contact us.
Akiko Iwasaki, PhD <> Andrew Miranker, PhD <> Anna Marie Pyle, PhD
Aaron Ring, PhD <> Paul Turner, PhD
On Thursday, September 17th, 250 attendees joined us to watch eight of Yale University's brightest innovators present their discovery and preclinical assets for partnering or investing opportunities.